封面
市場調查報告書
商品編碼
1616692

復健機器人市場機會、成長動力、產業趨勢分析及2024年至2032年預測

Rehabilitation Robots Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023年全球康復機器人市場價值為2.464億美元,預計2024-2032年複合年成長率為22.2%。大腦相關疾病盛行率的上升極大地推動了康復機器人市場的全球成長。中風、阿茲海默症、帕金森氏症和癲癇等疾病通常會導致長期殘疾,需要廣泛的復健治療。例如,世界衛生組織 (WHO) 報告稱,全球約有 5,000 萬人患有癲癇症,其中近 80% 居住在低收入和中等收入國家。此外,每年估計有 500 萬個新診斷病例。

隨著這些疾病變得越來越普遍,對有效復健策略的需求不斷增加。 2023 年,治療機器人領域引領市場,產生約 1.66 億美元的收入。

治療機器人提供一致、高品質的復健課程,通常減少對人類治療師的依賴。這不僅降低了整體復健成本,還允許更頻繁和延長療程,這對於有效康復至關重要,使其越來越受到患者的青睞。此外,治療機器人具有多功能性,可以解決中風以外的疾病,例如脊髓損傷、創傷性腦損傷、多發性硬化症和骨科問題。它們廣泛的適用性增強了它們在不同醫療保健環境中的價值。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 2.464 億美元
預測值 14億美元
複合年成長率 22.2%

市場也依機器人結構分為末端執行器機器人和外骨骼機器人。預計到 2032 年,末端執行器機器人領域將引領市場,預計收入約為 8.989 億美元。這種適應性允許進行多樣化的復健鍛煉,適合各種關節和肌肉群,從而滿足廣大患者的需求。此外,其方便用戶使用的設計意味著它們可以快速設置,並針對不同患者進行調整,並且不需要大量校準。

這種便利性對治療師和患者都有好處,確保臨床整合更加順利。中風、脊髓損傷、多發性硬化症和帕金森氏症等疾病在北美很普遍。隨著這些情況繼續惡化,預計將推動市場成長。

此外,北美醫療保健提供者擴大採用循證實踐,將機器人技術整合到復健計畫中,以改善患者的治療效果,進一步推動市場擴張。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 大腦相關疾病的盛行率上升
      • 身體殘障患者數量增加
      • 復健機器人技術的進步
      • 全球老年人口激增,創傷病例不斷增加
    • 產業陷阱與挑戰
      • 設備成本高
      • 發展中國家缺乏認知
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 報銷場景
  • 未來市場趨勢
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按類型,2021 - 2032

  • 主要趨勢
  • 輔助機器人
  • 治療機器人

第 6 章:市場估計與預測:按機器人結構,2021 - 2032 年

  • 主要趨勢
  • 末端執行器機器人
  • 外骨骼機器人

第 7 章:市場估計與預測:按極端,2021 - 2032

  • 主要趨勢
  • 上肢
  • 下肢

第 8 章:市場估計與預測:按患者分類,2021 - 2032 年

  • 主要趨勢
  • 成人
  • 兒科

第 9 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 後天性腦損傷
  • 脊髓損傷
  • 其他應用

第 10 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 復健中心
  • 其他最終用戶

第 11 章:市場估計與預測:按地區,2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 12 章:公司簡介

  • AlterG
  • Bionik Laboratories Corporation
  • Bioxtreme
  • Cyberdyne Inc.
  • DIH Medical
  • Ekso Bionics Holdings Inc.
  • Fourier Intelligence
  • Leaders Rehab Robot Co. Ltd.
  • MediTouch
  • Rehab-Robotics Company Limited
  • Reha-Stim Medtec AG
  • ReWalk Robotics
  • Rex Bionics Ltd
  • TYROMOTION GMBH
簡介目錄
Product Code: 5594

The Global Rehabilitation Robots Market was valued at USD 246.4 million in 2023 and is projected to expand at a CAGR of 22.2% from 2024-2032. The worldwide growth of the rehabilitation robot market is being significantly propelled by the rising prevalence of brain-related disorders. Conditions like stroke, Alzheimer's, Parkinson's, and epilepsy often lead to long-term disabilities, necessitating extensive rehabilitation. For example, the World Health Organization (WHO) reports that around 50 million people worldwide suffer from epilepsy, with nearly 80% residing in low- and middle-income nations. Furthermore, each year sees an estimated 5 million new diagnoses.

As these disorders become more prevalent, the demand for effective rehabilitation strategies intensifies.The overall rehabilitation robots industry is classified based on type, application, end-use, and region.The rehabilitation robots market is segmented by type into assistive robots and therapy robots. In 2023, the therapy robot segment led the market, generating approximately USD 166 million in revenue.

Therapy robots offer consistent, high-quality rehabilitation sessions, often diminishing the reliance on human therapists. This not only reduces overall rehabilitation costs but also permits more frequent and extended sessions, crucial for effective recovery, making them increasingly preferred by patients. Additionally, therapy robots boast versatility, addressing conditions beyond stroke, such as spinal cord injuries, traumatic brain injuries, multiple sclerosis, and orthopedic issues. Their broad applicability enhances their value across varied healthcare environments.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$246.4 Million
Forecast Value$1.4 Billion
CAGR22.2%

The market is also segmented by robotic structure into end-effector robots and exoskeleton robots. The end-effector robots segment is projected to lead the market with an anticipated revenue of around USD 898.9 million by 2032. End-effector robots enable a broad range of motion at their interaction point with patients, typically the hand or foot. This adaptability allows for diverse rehabilitation exercises, catering to various joints and muscle groups, thus meeting the needs of a wide patient demographic. Moreover, their user-friendly design means they can be swiftly set up, adjusted for different patients, and don't demand extensive calibration.

This accessibility benefits both therapists and patients, ensuring smoother clinical integration.In 2023, North America accounted for USD 106.9 million in revenue from the rehabilitation robots market and is poised for significant growth in the coming years. Conditions like stroke, spinal cord injuries, multiple sclerosis, and Parkinson's disease are prevalent in North America. As these conditions continue to rise, they are expected to fuel market growth.

Moreover, North American healthcare providers are increasingly adopting evidence-based practices, integrating robotics into rehabilitation programs to enhance patient outcomes, further propelling market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of brain-related disorders
      • 3.2.1.2 Increase in number of patients with physical disabilities
      • 3.2.1.3 Technological advancements in rehab robotics
      • 3.2.1.4 Surging geriatric population coupled with increasing trauma cases globally
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High device cost
      • 3.2.2.2 Lack of awareness in developing countries
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Regulatory landscape
  • 3.6 Reimbursement scenario
  • 3.7 Future market trends
  • 3.8 GAP analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Assistive robot
  • 5.3 Therapy robot

Chapter 6 Market Estimates and Forecast, By Robotic Structure, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 End-effector robots
  • 6.3 Exoskeleton robots

Chapter 7 Market Estimates and Forecast, By Extremity, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Upper extremity
  • 7.3 Lower extremity

Chapter 8 Market Estimates and Forecast, By Patient, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Adult
  • 8.3 Pediatric

Chapter 9 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Acquired brain injuries
  • 9.3 Spinal cord injuries
  • 9.4 Other applications

Chapter 10 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 Hospitals & clinics
  • 10.3 Rehabilitation centers
  • 10.4 Other end-users

Chapter 11 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Italy
    • 11.3.5 Spain
    • 11.3.6 Netherlands
    • 11.3.7 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Argentina
    • 11.5.4 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 South Africa
    • 11.6.3 UAE
    • 11.6.4 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 AlterG
  • 12.2 Bionik Laboratories Corporation
  • 12.3 Bioxtreme
  • 12.4 Cyberdyne Inc.
  • 12.5 DIH Medical
  • 12.6 Ekso Bionics Holdings Inc.
  • 12.7 Fourier Intelligence
  • 12.8 Leaders Rehab Robot Co. Ltd.
  • 12.9 MediTouch
  • 12.10 Rehab-Robotics Company Limited
  • 12.11 Reha-Stim Medtec AG
  • 12.12 ReWalk Robotics
  • 12.13 Rex Bionics Ltd
  • 12.14 TYROMOTION GMBH